XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Restricted Stock Activity
The following table summarizes the Company’s restricted stock unit activity:
SharesWeighted
Average
Grant Date
Fair Value
Unvested as of December 31, 202347,145 $202.27 
Issued197,097 51.98 
Vested(11,856)309.13 
Forfeited(9,712)54.86 
Unvested as of September 30, 2024222,674 $69.98 
Summary of Stock Option Activity
The following table summarizes the Company’s stock option activity:
Number of
Shares
Weighted
Average
Exercise Price
per Share
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic Value
(In years)(In thousands)
Outstanding as of December 31, 2023666,163 $160.19 
Granted1,195,546 51.43 
Exercised(8,753)39.75 $134 
Cancelled or Forfeited(23,632)127.76 
Outstanding as of September 30, 20241,829,324 $90.08 8.71$12,800 
Exercisable as of September 30, 2024878,111 $121.03 7.93$6,963 
Vested and expected to vest as of September 30, 20241,829,324 $90.08 8.71$12,800 
Schedule of Fair Value of Stock Option Awards on the Grant Date Using the Black-Scholes Option Valuation Model
The weighted-average assumptions that the Company used in the Black-Scholes option pricing model to determine the grant-date fair value of stock options granted to employees and non-employees on the date of grant were as follows for the three and nine months ended September 30, 2024:
Three Months Ended
September 30,
Nine Months Ended
September 30,
20242024
Risk-free interest rate4.06 %4.01 %
Expected term (in years)6.006.00
Expected volatility101.00 %96.48 %
Expected dividend yield— %— %
Weighted average grant-date fair value per share$45.95 $40.73 
Summary of Stock-Based Compensation Expense
Stock-based compensation expense was allocated as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2024202320242023
Research and development$4,640 $2,035 $12,298 $6,176 
General and administrative7,792 3,728 20,487 12,955 
Total stock-based compensation expense$12,432 $5,763 $32,785 $19,131